About
Basic Data Updated:
23 days agoSun Pharmaceutical Industries Limited, an Indian pharmaceutical company, is involved in the development, production, and promotion of formulations and APIs for various global markets. The company's business is divided into five main segments, which include India branded generics, US formulations, emerging markets for branded generics, the RoW business, and APIs. According to a credit rating report, SPIL, along with its acquisition of Ranbaxy Laboratories Limited in March 2015, holds a dominant market position in 10 different doctor categories within the domestic formulations market. Additionally, the company has an impressive 30 brands listed among the top-300 brands.
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Website12224421
- Telephone12224421
- Email Address12224421
- Social Media12224421
Products or Services related to Sun Pharmaceutical Industries Limited
Mineral Supplements
Respiratory Care
Mother Care
Pain Relief
Financials of Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 27.49% increase. The company also saw a substantial improvement in profitability, with a 1790.89% increase in profit. The company's net worth dipped by a decrease of 3.41%.
Corporate Structure
Unlock access to Sun Pharmaceutical Industries's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Sun Pharmaceutical Industries Limited
Unlock and access historical data on people associated with Sun Pharmaceutical Industries, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (3)
Anoop Deshpande
Company SecretaryAppointment Date: 31-Jan-2022
Status: Current
DS
Dilip Shanghvi Managing DirectorAppointment Date: 01-Apr-2008
Status: Current
CM
Chinnadharavaram Muralidharan CFOAppointment Date: 19-Jun-2017
Status: Current
Board Members(7)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Nvfc Finance Private Ltd Creation Date: 26 May 1999 | ₹7.50 M | Open |
Risk Capital And Technology Finance Corporation Ltd Creation Date: 29 Apr 1999 | ₹1.50 Cr | Open |
Industrial Development Bank Of India Creation Date: 17 Nov 1998 | ₹3.25 Cr | Open |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sun Pharmaceutical Industries, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sun Pharmaceutical Industries's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
Sun Pharma Laboratories Limited
Active
27 years 4 months Gautam Doshi, Sudhir Valia and 1 more are mutual person
Shantilal Shanghvi Foundation
Active 19 years 11 months Sudhir Valia and Dilip Shanghvi are mutual person
Recent activity within the organization
Annual General Meeting
Sun Pharmaceutical Industries Limited last Annual general meeting of members was held on 28 Aug 2023 as per latest MCA records.
28 Aug 2023Director Appointment
Aalok Dilip Shanghvi was appointed as a Whole-Time Director was appointed as a Whole-Time Director on 01 Jun 2023 & has been associated with this company since 11 months 18 days .
01 Jun 2023Balance Sheet
Sun Pharmaceutical Industries Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Ahmedabad.
31 Mar 2023Director Appointment
Sanjay Khatau Asher was appointed as a Director was appointed as a Director on 01 Nov 2022 & has been associated with this company since 1 year 6 months .
01 Nov 2022Charges
A charge registered on 31 Mar 2012 via Charge ID 10351563 with Others was fully satisfied on 20 Nov 2021.
20 Nov 2021
Recent News, Updates & Announcement
Sun Pharma beats the Street with 16 surge in Q3 net profit.Moneycontrol 31 Jan 2024
- Sun Pharma to buy remaining stake in Taro Pharma for 3478 million Details here Mint.
Sun Pharmaceutical Industries plans to acquire all outstanding shares of Taro Pharmaceutical Industries for 43 per share in cash aiming to gain complete control over its subsidiary.
mint 18 Jan 2024
- When Company Names Get Too Complicated The Struggle of SunPharmas Acronyms.
When you try to be fancy with your company name but end up just confusing everyone SunPharma TooManyAcronyms JustSaySun PharmaLife.
PR Newswire 17 Jan 2024
- Sun Pharma inks pact with Bayer to sell drug for chronic kidney disease.
Sun Pharma has partnered up with Bayer to market Finerenone a drug for chronic kidney disease in India Bayer grants nonexclusive rights to Sun Pharma to distribute Finerenone under the brand name Lyvelsa Sun Pharma CEO emphasizes commitment to providing innovative medicines to Indian patients .
Economic Times 17 Jan 2024
- Sun Pharma hits 52week high on acquiring Israeli company.
Moneycontrol 03 Jan 2024
Frequently asked questions
What is the Incorporation or founding date of Sun Pharmaceutical Industries Limited?
